Zhong et al. reported the molecular and cellular biology of four novel PRMT2 splice variants isolated from breast cancer cells, referred to as PRMT2L2, PRMT2α, PRMT2β, and PRMT2γ. Here, PRMT2 is linked to breast carcinoma.